Geriatrician gives 3 reasons older Americans should get the latest COVID jab now-ish

Early May will mark the first anniversary of the officially declared end of the COVID-19 public health emergency by the U.S. Department of Health and Human Services. Nevertheless, the Centers for Disease Control and Prevention continues urging Americans to keep up with updated vaccinations.

The agency is especially concerned about demographic groups at elevated risk for serious symptoms if infected. At the top of the list are adults 65 and older.

At the nonprofit, independent news site The Conversation, an academic geriatrician is helping spread the word.  

Laurie Archbald-Pannone, MD, of UVA Health in Virginia urges seniors to consider three reasons for getting a jab this spring. Here’s a summary.

1. Increased age means increased risk.

Compared with other age groups, older adults have the worst outcomes with a COVID-19 infection, Archbald-Pannone points out. “Increased age is, simply put, a major risk factor,” she adds. More:

Even now, four years after the start of the pandemic, people 65 years old and up are about twice as likely to die from COVID-19 than the rest of the population. People 75 years old and up are 10 times more likely to die from COVID-19.

2. Vaccination is still safe, effective—and more beneficial than risky.

Being appropriately vaccinated is “as critical in 2024 as it was in 2021 to help prevent infection, hospitalization and death” from COVID-19, Archbald-Pannone writes. More:

The updated COVID-19 vaccine has been shown to be safe and effective, with the benefits of vaccination continuing to outweigh the potential risks of infection.

3. Long COVID can compromise the immune system.

Keeping up to date with COVID-19 immunization “has a fourfold decrease in risk of developing ‘long COVID’ symptoms if you do get infected,” Archbald-Pannone notes. “Known as immunosenescence, this puts people at higher risk of infection, including severe infection, and decreased ability to maintain immune response to vaccination as they get older.” More:

The older one gets—over 75, or over 65 with other medical conditions—the more immunosenescence takes effect.

“All this is why, if you’re in this age group, even if you received your last COVID-19 vaccine in fall 2023, the spring 2024 shot is still essential to boost your immune system so it can act quickly if you are exposed to the virus,” Archbald-Pannone concludes. “The bottom line: If you’re 65 or older, it’s time for another COVID-19 shot.”

 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.